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pyrazol-3-yl)-2H-chromen-2-one derivatives
Olayinka O. Ajania, Maria M. Akandea, Natasha Octoberb, Tolutope O. Siyanbolaa , Damilola
V. Aderohunmua , Anuoluwa A. Akinsikua and Shade J. Olorunsholac
aDepartment of Chemistry, Covenant University, CST, Ota, Ogun State, Nigeria; bDepartment of Chemistry, University of Pretoria,
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ABSTRACT
A variety of 3-(5-(substituted-phenyl)-4,5-dihydro-1H-pyrazol-3-yl)-2H-chromen-2-one deriva-
tives 3a–j were synthesized through microwave assisted thermal annulation of correspond-
ing a,b-unsaturated ketones (chalcones) 2a–j via hydrazinolysis. Chalcones 2a–j were
prepared from 3-acetyl-coumarin 1 which was previously accessed by Pechmann condensa-
tion reaction of salicylaldehyde. The series of pyrazoline-based coumarin motifs 3a–j synthe-
sized, were structurally confirmed by analytical and spectral data. They were then evaluated
for their antimicrobial activities using agar diffusion method. The result showed that micro-
wave assisted method (MAM) for the reaction was remarkably successful and gave the tar-
geted products 3a–j in higher yields at shorter reaction times compared to conventional
synthetic method (CSM). The results showed that these skeletal frameworks exhibited
marked potency as antibacterial agents. The most active antibacterial agent was 3-(5-(4-
(diethylamino) phenyl)-4,5-dihydro-1H-pyrazol-3-yl)-2H-chromen-2-one 3j with MIC and MBC
values of 3.92±0.22mg/mL and 7.82 ± 0.43mg/mL respectively.
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In the recent times, green chemistry possesses the
spirit of sustainable development and is attracting
increasing interest in the 21st century (Yue et al.,
2011). Microwave-assisted reactions, as green
approaches, have been intensely investigated since
the earliest publication of Gedye et al. (1986). This
methodology can be included within the concept of
Green Chemistry because the strong absorption of
microwave irradiation by one component of the
reaction would lead to shorter reaction times and
improved energy efficiency (de la Hoz et al., 2016). It
has led to accelerated eco-friendly synthesis of vari-
ous titled sulfur-containing (G€um€uş & Elemes, 2018)
and nitrogen-containing heterocycles (Ajani,
Aderohunmu, et al., 2018). Heterocycles are known
to be one of the largest areas of research in organic
chemistry and medicinal research (Ajani, 2014). Many
naturally occurring substances, traditionally used in
popular medicines around the world, contain the
coumarin moiety (Stefanachi et al., 2018). Some of
the natural origins of coumarin moieties are plants
such as Dipteryx odorata, Calophyllum sp. and
Hedysarum multijugum. Due to their broad ranges of
biological activities, they have also enjoyed labora-
tory preparation both in micro-scale and large-scale
media. Coumarin and its fused derivatives have been
reported to possess diverse pharmacological activ-
ities such as antimicrobial (Widelski et al., 2018), anti-
cancer (Bouhenna et al., 2018), anti-inflammatory
(Chavan & Hosamani, 2018), anti-HIV (Srivastav et al.,
2018), antioxidant (Perez-Cruz et al., 2018), antimalar-
ial (Hu et al., 2018), antitumor (Amin et al., 2018),
anti-HCV (Peng et al., 2013), antihyperlipidemic (Iyer
& Patil, 2014) and antitubercular (Patel et al.,
2013) activities.
Furthermore, muscle relaxant and sedative hyp-
notic activities of extract containing 4-hydroxycou-
marin has been reported (Muhammad et al., 2013). A
critical analysis of various reports on naturally as well
as the synthetically derived coumarin templates with
anti-inflammatory activity have been carried out
(Bansal et al., 2013). In the recent review by Patil
et al. (2013), coumarin moieties was highly projected
as Monoamine oxidase (MAO) enzyme inhibitor
which is a crucial target for the management of
depression and Alzheimer disease. Coumarin frame-
work was reported as new protector of amyloid
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beta-induced neurotoxicity through the mitochon-
drial-dependent pathway (Song et al., 2013). In add-
ition, they are widely used as food additives (Wei
et al., 2018), chiroptical (Delcourt et al., 2019), per-
fumes, cosmetics, pharmaceuticals (Pereira et al.,
2018), insecticides, optical brightening agents
(Chatterjee & Seth, 2013), dispersed fluorescent and
laser dyes (Acar et al., 2015). In a similar manner, the
use of pyrazole as precursor for the synthesis of bio-
active motifs (El Azab et al., 2019) and evaluation of
their chemical behaviours have gained more import-
ance in the recent decades for tumor cell growth
inhibition (Cui et al., 2019) and agricultural
(Venkateswarlu et al., 2018) applications. The chemis-
try of carbon–nitrogen double bond of hydrazone is
fast becoming the backbone of condensation reac-
tion in benzo-fused N-heterocycles (Ajani, Iyaye,
et al., 2018), especially, in the synthesis of pyrazole-
bearing motifs.
In view of the occurrence of microorganisms’ resist-
ance, increase in severe opportunistic microbial infec-
tions (Aslam et al., 2018) and the emergence of new
diseases, there is a continuous need for the fast syn-
thesis of new bioactive heterocyclic compounds as
potential therapeutic agents. The combination of two
different and independently linked hybrid compounds
can display synergy and result in a pharmacological
potency greater than the sum of each individual moi-
ety’s potency (Pawelczyk et al., 2018). Hence, we have
herein investigated the microwave assisted synthesis
of pyrazoline-linked coumarin as a green synthetic
approach to access biologically active coumarin scaf-
folds. It was envisaged that the pyrazole insertion in
coumarin will create a synergistic effect to boost the
activity of the titled compounds.
2. Materials and methods
2.1. General condition
All the solvents and reagents used were purchased
from Sigma-Aldrich Chemicals, USA except anisalde-
hyde and benzaldehyde which were obtained from
J.T. Baker Chemicals, UK and hydrazine hydrate and
piperidine which were obtained from BDH England.
Chemicals used were of analytical grade and, were
used directly without any further purification. Melting
points were determined in open capillary tubes on
Stuart melting point apparatus and were uncorrected.
The 1H-NMR and 13C-NMR spectral analyses were run
using deuterated dimethyl sulfoxide (DMSO-d6) solv-
ent at 400MHz and 100MHz respectively, with
Tetramethyl silane (TMS) being used as the internal
standard. The machine used was NMR Bruker DPX 400
spectrometer and chemical shifts d were recorded in
parts per million (ppm). The IR spectra were run in
solid state using the Bruker FT-IR; while UV-visible
spectrophotometric analyses of all the samples were
run in dichloromethane (CH2Cl2), Dimethyl sulphoxide
and acetone using UV-Genesys spectrophotometer.
The progress of the reaction and the level of purity of
the prepared compounds were routinely checked by
Thin Layer Chromatography (TLC) on silica gel plates
using different solvent system based on the variation
of polarity of the product of interest and the devel-
oped plates were visualized under UV light where
necessary. In a situation where more than one spots
were observed, column chromatography was used as
the purification technique. The microwave assisted
syntheses were carried out using a CEM Discover
monomode oven operating at 2450MHz monitored
by a PC computer and temperature maintained at a
constant value (140 C) within the power modulation
of 500W within a ramp time of 1–3min. After reaction
was completed, solvents were evaporated under
reduced pressure using IKAVR RV 10 Rotary evaporator.
2.2. Synthetic chemistry procedure
2.2.1. Synthesis of 3-acetyl-coumarin or 3-acetyl-
2H-chromen-2-one (1)
A mixture of ethyl acetoacetate (11.5ml, 90.13mmol)
and salicylaldehyde (8.6ml, 81.89mmol) was catalyzed
with piperidine (0.2ml, 1.64mmol), and heated under
reflux for a period of 20min to produce a crude solid
mass of 3-acetyl-coumarin (TLC monitored). The crude
solid was recrystallized from methanol to afford yel-
low crystal of pure 3-acetyl-coumarin, 1 (15.48 g,
99.6%). 1H-NMR (CDCl3, 400MHz) d: 2.27 (s, 3 H, CH3),
7.42–7.84 (m, 4 H, Benzofused coumarin-H), 8.57 (s,
1 H, Coumarin-H). 13C-NMR (CDCl3, 100Hz) dC: 198.7
(C ¼ O), 159.4 (C ¼ O), 153.0, 137.4, 131.2, 128.3,
127.9, 125.4, 118.1, 116.1, 29.6 (CH3) ppm. DEPT 135
NMR: þve signals 137.4, 131.2, 127.9, 125.4, 116.1,
29.6 (CH3) ppm. þve signals nil. MS: m/z 188 (Mþ,
80%), 145 (100%), 94 (50%). UV-Visible spectral data
! kmax (Log e): 216 (5.29), 236 (4.65), 288 (4.57), 327
(4.57), 348 (4.49), 355 (4.24), 369 (4.01). IR (KBr): 2925
(CH aliphatic), 1746 (C ¼ O ester), 1685 (C ¼ O), 1606
(C ¼ C), 1369 (C-O) cm1.
2.2.2. Microwave assisted synthesis of 3-cinna-
moyl-2H-chromen-2-one (2a)
Equimolar amount of 3-acetyl-coumarin (3.00 g,
16.00mmol) and benzaldehyde (1.62mL, 16.00mmol)
were mixed together followed by addition of a cata-
lytic amount of piperidine (5 drops). The mixture was
swirled and irradiated in microwave oven until the
reaction was completed (1min). The progress of reac-
tion was monitored using Thin Layer Chromatography
(TLC) (eluting solvent: Dichloromethane) before the
reaction was terminated. The product was recrystal-
lized from ethanol to afford compound 2a. The same
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procedure for synthesis of 2a was repeated for other
benzaldehyde derivatives to afford 2b–j. The detail of
the spectral data of reactive intermediates 2a–j is as
presented in supplementary material.
2.2.3. General procedure for synthesis of 3-(substi-
tuted-phenyl-4,5-dihydro-1H-pyrazol-3-yl)-2H-chro-
men-2-one (3a–j)
Method A (MAM): Hydrazine hydrate (0.36mL,
7.20mmol) was added to each of the compounds 3-
(3-(substituted-phenyl)acryloyl)-2H-chromen-2-one
2a–j (7.20mmol) in sealed tube and the mixture was
irradiated in microwave oven for a required period
of time. Upon reaction completion as indicated by
TLC monitoring, the resulting mixture was cooled to
ambient temperature to give a crude compound
which was recrystallized from ethanol. The product
was then cooled, filtered and air-dried to afford cor-
responding pyrazoline-based coumarin 3a–j in vary-
ing percentage yields.
Method B (CSM): Each of the required intermediates
3-(3-(substituted-phenyl)acryloyl)-2H-chromen-2-one
2a–j (7.20mmol) was dissolved in 20mL of ethanol in
a 250mL round bottomed quick-fit flask and stirred at
room temperature for 5min. Hydrazine hydrate
(0.36mL, 7.20mmol) was cautiously added to the solu-
tion and the resulting mixture was then heated under
reflux via conventional method for a total of 5 to 6 h
before the starting material was totally consumed
which was an indication of reaction completion (moni-
tored by TLC). The solvent was concentrated and
cooled to afford solid which was recrystallized from
ethanol/water or column chromatography where
necessary to afford the envisaged products 3a–j.
2.2.3.1. 3-(5-phenyl-4,5-dihydro-1H-pyrazol-3-yl)-
2H-chromen-2-one, (3a). Reagents: 3-Cinnamoyl-2H-
chromen-2-one 2a (2.00 g, 7.20mmol), hydrazine
hydrate (0.36mL, 7.20mmol), Conditions: MWI for 11=2
min, 140 C. Purification: recrystallization (ethanol). 1H-
NMR (DMSO-d6, 400MHz) dH: 8.64 (s, 1 H, Het-H),
7.96–7.94 (d, J ¼ 7.68 Hz, 1 H, Ar-H), 7.76–7.72 (t,
J ¼ 7.68 Hz, 1 H, Ar-H), 7.44–7.40 (m, 2 H, Ar-H), 7.23 (s,
5 H, Ar-H), 6.83–6.81 (d, J ¼ 9.64Hz, 1 H, NH-CH),
3.36–3.31 (m, 1 H, CH), 2.59–2.58 (d, J ¼ 4.56 Hz, 2 H,
CH2-CH).
13C-NMR (DMSO-d6, 100MHz) dC: 195.0
(C ¼ O), 154.0 (C-O), 147.0, 138.3, 136.7, 134.4, 130.7,
128.9, 124.9, 124.3, 123.0, 120.8, 118.1, 116.0, 114.8,
113.5, 58.4 (CH), 45.6 (CH2) ppm. DEPT 135 NMR: þve
signals 147.0, 138.3, 136.7, 134.4, 130.7, 124.9, 123.0,
120.8, 116.0, 114.8, 58.4 (CH) ppm; ve signal 45.6
(CH2) ppm. UV-Visible spectral data ! kmax (Log e):
221 (3.33), 239 (3.55), 290 (3.63), 353 (3.44). FT-IR (KBr):
3421 (N-H), 3042 (CH aromatic), 2964 (CH aliphatic),
1755 (C ¼ O of ester), 1605 (C ¼ C), 1593 (C ¼ N),




chromen-2-one 2b (2.30 g, 7.20mmol), hydrazine
hydrate (0.36mL, 7.20mmol), Conditions: MWI for
11=2 min, 140 C. Purification: recrystallization (etha-
nol). 1H-NMR (DMSO-d6, 400MHz) dH: 8.64 (s, 1 H,
Het-H), 7.96–7.94 (d, J ¼ 7.70Hz, 1H, Ar-H),
7.76–7.73 (t, J ¼ 7.68Hz, 1 H, Ar-H), 7.60–7.58 (d,
J ¼ 8.00Hz, 2 H, Ar-H), 7.46–7.42 (m, 2 H, Ar-H),
7.24–7.22 (d, J ¼ 8.00 Hz, 2 H, Ar-H), 6.94–6.91 (d,
J ¼ 9.64Hz, 1 H, NH-CH), 3.41–3.36 (m, 1 H, CH),
2.60–2.59 (d, J ¼ 4.58Hz, 2 H, CH2-CH), 2.35 (s, 6 H,
CH3-N-CH3).
13C-NMR (DMSO-d6, 100MHz) dC: 195.0
(C ¼ O), 154.5 (C-O), 147.0, 145.4, 138.3, 136.4, 134.3,
130.7, 129.2, 125.4, 124.2, 122.5, 120.1, 118.1, 116.0,
113.1, 59.4 (CH), 45.8 (CH2), 29.5 (2CH3) ppm.
DEPT 135 NMR: þve signals 147.0, 138.3, 136.4,
134.3, 130.7, 125.4, 122.5, 120.1, 116.0, 59.4 (CH),
29.5 (2CH3) ppm. ve signal 45.8 (CH2) ppm. UV-
Visible spectral data ! kmax (Log e): 227 (3.06), 257
(3.36), 320 (3.18), 392 (3.57). FT-IR (KBr): 3412 (N-H),
2910 (CH aliphatic), 1746 (C ¼ O of ester), 1601
(C ¼ C), 1584 (C ¼ N), 1364 (C-O of ester), 1228 (C-




2H-chromen-2-one 2c (2.32 g, 7.20mmol), hydrazine
hydrate (0.36mL, 7.20mmol), Conditions: MWI for
2min, 140 C. Purification: recrystallization (ethanol).
1H-NMR (DMSO-d6, 400MHz) dH: 8.64 (s, 1 H, Het-H),
8.42 (s, 1 H, Ar-OH), 7.96–7.93 (d, J ¼ 8.50Hz, 1 H, Ar-
H), 7.76–7.73 (t, J ¼ 7.98 Hz, 1 H, Ar-H), 7.57–7.55 (d,
J ¼ 7.70Hz, 1 H, Ar-H), 7.44–7.41 (m, 2 H, Ar-H),
7.31–7.29 (d, J ¼ 8.00 Hz, 1 H, Ar-H), 7.11–7.09 (d,
J ¼ 8.00Hz, 1 H, Ar-H), 6.85–6.83 (d, J ¼ 9.04 Hz, 1 H,
NH-CH), 3.36–3.31 (m, 1 H, CH), 2.60–2.58 (d,
J ¼ 4.98Hz, 2 H, CH2-CH), 2.20 (s, 3 H, OCH3). 13C-
NMR (DMSO-d6, 100MHz) dc: 195.0 (C ¼ O), 154.5,
147.0, 143.2, 141.0, 138.3, 136.4, 134.3, 130.7, 219.2,
124.9, 124.3, 122.9, 118.1, 116.0, 113.1, 59.4 (CH),
45.8 (CH2), 29.5 (CH3) ppm. DEPT 135 NMR: þve sig-
nals 147.0, 138.3, 136.4, 134.3, 124.9, 122.9, 116.0,
59.4 (CHs), 29.5 (CH3) ppm; ve signal 45.8 (CH2)
ppm. UV-Visible spectral data ! kmax (Log e): 226
(3.20 s), 253 (3.90 s), 282 (3.75 s), 353 (4.016). FT-IR
(KBr): 3350 (OH), 2980 (CH aliphatic), 1750 (C ¼ O of
ester), 1618 (C ¼ C aromatic), 1572 (C ¼ N), 1374 (C-
O of ester), 1225 (C-N), 1044 (C-O of phenol), 747
(Ar-H) cm1.
2.2.3.4. 3-(5-(4-ethoxyphenyl)-4,5-dihydro-1H-pyra-
zol-3-yl)-2H-chromen-2-one (3d). Reagents: 3-(3-(4-
Ethoxyphenyl)acryloyl)-2H-chromen-2-one 2d (2.31 g,
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7.20mmol), hydrazine hydrate (0.36mL, 7.20mmol),
Conditions: MWI for 3min, 140 C. Purification:
recrystallization (ethanol). 1H-NMR (DMSO-d6,
400MHz) dH: 8.64 (s, 1 H, Het-H), 7.96–7.93 (d,
J ¼ 8.66 Hz, 1 H, Ar-H), 7.77–7.74 (t, J ¼ 7.94 Hz, 1 H,
Ar-H), 7.62–7.60 (d, J ¼ 8.00Hz, 2 H, Ar-H), 7.46–7.40
(m, 2 H, Ar-H), 7.23–7.21 (d, J ¼ 8.00 Hz, 2 H, Ar-H),
6.94–6.91 (d, J ¼ 9.14Hz, 1 H, NH-CH), 3.40–3.36 (m,
1 H, CH), 3.12–3.08 (q, J ¼ 8.80 Hz, 2 H, CH2-CH3),
2.60–2.55 (d, J ¼ 5.06Hz, 2 H, CH2-CH), 2.35–2.30 (t,
J ¼ 8.80 Hz, 2 H, CH3-CH2). 13C-NMR (DMSO-d6,
100MHz) dc: 195.5 (C ¼ O), 154.5, 147.0, 144.7, 140.4,
138.3, 136.7, 134.5, 130.7, 128.8, 124.9, 124.4, 123.0,
120.1, 118.1, 116.0, 59.2 (CH), 52.4 (O-CH2), 45.6
(CH2), 26.4 (CH3) ppm. DEPT 135 NMR: þve signals
147.0, 138.3, 136.7, 134.5, 124.9, 123.0, 120.1, 116.0,
59.2 (CHs), 26.4 (CH3) ppm; ve signal 45.6 (CH2)
ppm. UV-Visible spectral data ! kmax (Log e): 215
(3.23), 258 (3.75 s), 284 (3.95), 340 (4.05). FT-IR (KBr):
3418 (N-H), 2936 (CH aliphatic), 1747 (C ¼ O of
ester), 1610 (C ¼ C aromatic), 1591 (C ¼ N), 1373 (C-
O of ester), 1227 (C-N), 746 (Ar-H) cm1.
2.2.3.5. 3-(5-(4-chlorophenyl)-4,5-dihydro-1H-pyra-
zol-3-yl)-2H-chromen-2-one (3e). Reagents: 3-(3-(4-
Chlorophenyl)acryloyl)-2H-chromen-2-one 2e (2.24 g,
7.20mmol), hydrazine hydrate (0.36mL, 7.20mmol),
Conditions: MWI for 11=2 min, 140 C. Purification:
recrystallization (ethanol). 1H-NMR (DMSO-d6,
400MHz) dH: 8.61 (s, 1 H, Het-H), 7.96–7.94 (d,
J ¼ 8.00 Hz, 1 H, Ar-H), 7.75–7.72 (t, J ¼ 7.98 Hz, 1 H,
Ar-H), 7.62–7.60 (d, J ¼ 8.20Hz, 2 H, Ar-H), 7.46–7.42
(m, 2 H, Ar-H), 7.26–7.24 (d, J ¼ 8.22 Hz, 2 H, Ar-H),
6.94–6.93 (d, J ¼ 7.68Hz, 1 H, NH-CH), 3.41–3.36 (m,
1 H, CH), 2.60–2.57 (d, J ¼ 4.96 Hz, 2 H, CH2-CH). 13C-
NMR (DMSO-d6, 100MHz) dc: 194.8 (C ¼ O), 154.3,
151.4, 146.8, 144.6, 140.4, 138.4 (2CH), 134.4,
130.3, 128.9, 125.1, 124.3, 123.1 (2CH), 118.1,
115.5, 60.2 (CHs), 47.5 (CH2) ppm. DEPT 135 NMR:
þve signals 146.8, 138.4 (2CH), 134.4, 130.3, 125.1,
123.1 (2CH), 115.5, 60.2 (CHs), ppm; -ve signal 47.5
(CH2) ppm. UV-Visible spectral data ! kmax (Log e):
221 (3.13), 240 (3.30), 256 (3.60 s), 293 (3.84), 358
(3.51). FT-IR (KBr): 3420 (N-H), 2930 (CH aliphatic),
1747 (C ¼ O of ester), 1606 (C ¼ C), 1575 (C ¼ N),
1748 (C ¼ O of ester), 1363 (C-O of ester), 1224 (C-
N), 749 (Ar-H) cm1.
2.2.3.6. 3-(5-(3-hydroxyphenyl)-4,5-dihydro-1H-pyr-
azol-3-yl)-2H-chromen-2-one (3f). Reagents: 3-(3-(3-
Hydroxyphenyl)acryloyl)-2H-chromen-2-one 2f (2.10 g,
7.20mmol), hydrazine hydrate (0.36mL, 7.20mmol),
Conditions: MWI for 3min, 140 C. Purification: recrys-
tallization (ethanol). 1H-NMR (DMSO-d6, 400MHz) dH:
8.88 (s, 1 H, Ar-OH), 8.61 (s, 1 H, Het-H), 7.96–7.94
(d, J ¼ 8.00Hz, 1 H, Ar-H), 7.76–7.72 (m, 1 H, Ar-H),
7.56 (s, 1 H, Ar-H), 7.46–7.44 (m, 2 H, Ar-H), 7.31–7.29
(d, J ¼ 8.16Hz, 1 H, Ar-H), 7.11–7.09 (d, J ¼ 8.22 Hz,
1 H, Ar-H), 6.85–6.83 (d, J ¼ 7.96 Hz, 1 H, NH-CH),
3.36–3.31 (m, 1 H, CH), 2.59–2.57 (d, J ¼ 5.18 Hz, 2 H,
CH2-CH).
13C-NMR (DMSO-d6, 100MHz) dc: 195.0,
156.1, 154.5, 152.2, 147.0, 145.1, 141.7, 137.6, 134.4,
130.7, 124.9, 124.3, 121.4, 118.1, 116.0, 113.5, 58.4
(CHs), 46.2 (CH2) ppm. DEPT 135 NMR: þve signals
152.2, 147.0, 141.7, 137.6, 134.4, 130.7, 124.9, 121.4,
116.0, 58.4 (CHs) ppm; -ve signal 46.2 (CH2) ppm. UV-
Visible spectral data ! kmax (Log e): 212 (3.14), 257
(3.47 s), 287 (3.70), 340 (3.62). FT-IR (KBr): 3345 (O-H),
2973 (CH aliphatic), 1750 (C ¼ O of ester), 1615
(C ¼ C), 1579 (C ¼ N), 1371 (C-O of ester), 1220 (C-N),
1043 (C-O of phenol), 750 (Ar-H) cm1.
2.2.3.7. 3-(5-(4-hydroxyphenyl)-4,5-dihydro-1H-pyr-
azol-3-yl)-2H-chromen-2-one (3 g). Reagents: 3-(3-
(4-Hydroxyphenyl)acryloyl)-2H-chromen-2-one 2g
(2.10 g, 7.20mmol), hydrazine hydrate (0.36mL,
7.20mmol), Conditions: MWI for 1min, 140 C.
Purification: recrystallization (ethanol). 1H-NMR
(DMSO-d6, 400MHz) dH: 8.80 (s, 1 H, Ar-OH), 8.64 (s,
1 H, Het-H), 7.96–7.94 (d, J ¼ 8.00Hz, 1 H, Ar-H),
7.77–7.73 (m, 1 H, Ar-H), 7.63–7.60 (d, J ¼ 8.58Hz,
2 H, Ar-H), 7.46–7.42 (m, 2H, Ar-H), 7.25–7.22 (d,
J ¼ 8.42Hz, 2 H, Ar-H), 6.84–6.82 (d, J ¼ 7.96 Hz, 1 H,
NH-CH), 3.41–3.36 (m, 1 H, CH), 2.59–2.57 (d,
J ¼ 5.18Hz, 2 H, CH2-CH). 13C-NMR (DMSO-d6,
100MHz) dc: 195.4, 157.0, 154.9, 151.2, 147.0, 140.4
(2 CH), 142.9, 137.7, 130.7, 127.8, 121.7 (2CH),
118.1, 116.0, 113.5, 59.3 (CHs) ppm. DEPT 135 NMR:
þve signals 151.2, 147.0, 140.4 (2 CH), 137.7, 130.7,
121.7 (2CH), 116.0, 59.3 (CHs) ppm; -ve signal 47.2
(CH2) ppm. UV-Visible spectral data ! kmax (Log e):
255 (3.83 s), 280 (4.07), 315 (3.93). FT-IR (KBr): 3350
(OH), 2923 (CH aliphatic), 1745 (C ¼ O of ester),
1605 (C ¼ C aromatic), 1588 (C ¼ N), 1372 (C-O of
ester), 1226 (C-N), 1044 (C-O of phenol), 747 (Ar-
H) cm1.
2.2.3.8. 3-(5-(3-methoxyphenyl)-4,5-dihydro-1H-
pyrazol-3-yl)-2H-chromen-2-one (3 h). Reagents: 3-
(3-(3-Methoxyphenyl)acryloyl)-2H-chromen-2-one 2h
(2.21 g, 7.20mmol), hydrazine hydrate (0.36mL,
7.20mmol), Conditions: MWI for 21=2 min, 140 C.
Purification: recrystallization (ethanol). 1H-NMR
(DMSO-d6, 400MHz) dH: 8.64 (s, 1 H, Het-H),
7.95–7.93 (d, J ¼ 8.00 Hz, 1 H, Ar-H), 7.75–7.72 (m,
1 H, Ar-H), 7.56 (s, 1 H, Ar-H), 7.46–7.43 (m, 2 H, Ar-H),
7.96–7.94 (d, J ¼ 8.00 Hz, 1 H, Ar-H), 7.31–7.29 (d,
J ¼ 8.42Hz, 1 H, Ar-H), 7.15–7.13 (d, J ¼ 7.88 Hz, 1 H,
Ar-H), 6.84–6.82 (d, J ¼ 7.96Hz, 1 H, NH-CH),
3.36–3.31 (m, 1 H, CH), 2.60–2.57 (d, J ¼ 5.18Hz, 2 H,
CH2-CH), 2.25 (s, 3 H, Ar-OCH3).
13C-NMR (DMSO-d6,
100MHz) dc: 195.0 (C ¼ O), 154.3, 150.9, 146.8, 143.3,
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140.8, 138.1, 136.4, 134.4, 127.3, 124.9, 123.1, 118.1,
116.0, 113.8, 111.7, 58.6 (CHs), 46.3 (CH2), 29.5 (CH3)
ppm. DEPT 135 NMR: þve signals 150.9, 146.8, 138.1,
136.4, 134.4, 127.3, 124.9, 123.1, 116.0, 111.7, 58.6
(CHs), 29.5 (CH3) ppm; -ve signal 46.3 (CH2) ppm. UV-
Visible spectral data ! kmax (Log e): 227 (3.05), 258
(2.80 s), 281 (3.62), 353 (3.38). FT-IR (KBr): 3412 (N-H),
2933 (CH aliphatic), 1745 (C ¼ O of ester), 1606
(C ¼ C aromatic), 1576 (C ¼ N), 1365 (C-O of ester),
1224 (C-N), 750 (Ar-H) cm1.
2.2.3.9. 3-(5-(4-methoxyphenyl)-4,5-dihydro-1H-
pyrazol-3-yl)-2H-chromen-2-one (3i). Reagents: 3-
(3-(4-Methoxyphenyl)acryloyl)-2H-chromen-2-one 2i
(2.21 g, 7.20mmol), hydrazine hydrate (0.36mL,
7.20mmol), Conditions: MWI for 11=2 min, 140 C.
Purification: recrystallization (ethanol). 1H-NMR
(DMSO-d6, 400MHz) dH: 8.64 (s, 1 H, Het-H),
7.95–7.93 (d, J ¼ 8.48Hz, 1 H, Ar-H), 7.77–7.74 (m,
1 H, Ar-H), 7.60–7.58 (d, J ¼ 8.00 Hz, 2 H, Ar-H),
7.46–7.40 (m, 2 H, Ar-H), 7.25–7.23 (d, J ¼ 8.00 Hz,
2 H, Ar-H), 6.84–6.82 (d, J ¼ 8.56Hz, 1 H, NH-CH),
3.36–3.31 (m, 1 H, CH), 2.60–2.59 (d, J ¼ 6.18 Hz, 2 H,
CH2-CH), 2.20 (s, 3 H, Ar-OCH3).
13C-NMR (DMSO-d6,
100MHz) dc: 194.5 (C ¼ O), 154.7, 151.6, 147.1, 143.7,
141.0, 138.6, 136.4, 134.4, 127.3, 124.9, 122.7, 118.2,
116.2, 113.5, 111.1, 58.6 (CHs), 46.3 (CH2), 29.9 (CH3)
ppm. DEPT 135 NMR: þve signals 147.1, 138.6, 136.4,
134.4, 127.3, 124.9, 122.7, 116.2, 111.1, 58.6 (CHs),
29.9 (CH3) ppm; -ve signal 46.3 (CH2) ppm. UV-Visible
spectral data ! kmax (Log e): 218 (3.11), 257 (3.36),
320 (3.18), 392 (3.57). FT-IR (KBr): 3443 (N-H of
2oamine), 2930 (CH aliphatic), 1745 (C ¼ O of ester),
1620 (C ¼ C), 1573 (C ¼ N), 1372 (C-O of ester),




one 2j (2.50 g, 7.20mmol), hydrazine hydrate
(0.36mL, 7.20mmol), Conditions: MWI for 21=2 min,
140 C. Purification: recrystallization (ethanol). 1H-
NMR (DMSO-d6, 400MHz) dH: 8.69 (s, 1 H, Het-H),
7.95–7.93 (d, J ¼ 8.58Hz, 1 H, Ar-H), 7.75–7.73 (m,
1 H, Ar-H), 7.58–7.56 (d, J ¼ 8.00 Hz, 2 H, Ar-H),
7.46–7.42 (m, 2 H, Ar-H), 7.22–7.20 (d, J ¼ 8.00 Hz,
2 H, Ar-H), 6.94–6.91 (d, J ¼ 8.56Hz, 1 H, NH-CH),
3.40–3.36 (m, 1H, CH), 3.14–3.13 (q, J ¼ 2.44 Hz, 4 H,
2CH2-CH3), 2.59–2.57 (d, J ¼ 6.20 Hz, 2H, CH2-CH),
2.33–2.32 (t, J ¼ 2.44Hz, 4 H, 2CH3-CH2). 13C-NMR
(DMSO-d6, 100MHz) dc: 195.4 (C ¼ O), 158.0, 154.9,
152.0, 147.0, 142.9, 140.6, 138.2 (2CH), 131.0,
128.0, 122.2 (2CH), 118.5, 116.4, 109.9, 59.2 (CHs),
50.8 (2CH2), 47.2 (CH2), 19.5 (2CH3) ppm. DEPT
135 NMR: þve signals 152.0, 147.0, 138.2 (2CH),
131.0, 122.2 (2CH), 116.4, 109.9, 59.2 (CHs), 19.5
(2CH3) ppm; -ve signal 50.8 (2CH2), 47.2 (CH2)
ppm. UV-Visible spectral data ! kmax (Log e): 227
(2.92), 226 (3.00), 265 (3.00 s), 398 (3.37), 575 (1.60).
FT-IR (KBr): 3420 (N-H), 2969 (CH aliphatic), 1750
(C ¼ O of ester), 1601 (C ¼ C aromatic), 1575
(C ¼ N), 1362 (C-O of ester), 1227 (C-N), 747 (Ar-H),
603 (N-H wagging) cm1.
2.2.4. Antibacterial activity assay
The typed bacterial isolates used obtained from
Nigeria Institute of Medical Research include
Staphylococcus aureus (ATCC 25923), Klebsiella pneu-
moniae (ATCC 13182), Pseudomonas aeruginosa
(ATCC 15442), and Escherichia coli (ATCC 25922)
while Streptococcus faecalis and Proteus vulgaris were
locally isolated organisms (LIO) using Analytical
Profile Index (API) Kit. All the isolates were further
subjected to biochemical tests for confirmation.
2.2.4.1. Antibacterial sensitivity testing of com-
pounds 3a–j. All the synthesized pyrazoline-based
coumarins 3a–j and gentamicin clinical standard were
screened for antibacterial activity on six bacterial
strains using agar well diffusion method (Ajani et al.,
2010). The general sensitivity testing was carried out
with medium employed was diagnostic medium agar
from Biotech Limited. Addition of about 0.2mL of the
broth culture to 18mL sterile molten diagnostic sensi-
tivity test agar (Biotech Ltd) was cautiously done and
the mixture was cooled down to 45 C. This mixture
was poured into petri dishes which were previously
sterilized prior to use and then labeled with respect to
the test organisms. The medium was then allowed to
set. Sterile cork borer was utilized to bore the neces-
sary numbers of holes into the medium. The wells
were made of to the edge of the plate. The wells
which were made of about 5mm to plate edge, were
filled up aseptically with the compound dissolved in
DMSO. Gentamicin was used as the standard antibac-
terial agent at a concentration of 1000mg/mL.
Effective diffusion of the antibacterial agents into the
medium was achieved by allowing the plate to stand
for 1 h, followed by upright incubation at 37 C for
24 h. Care was taken not to stockpile the plates. Clear
zones of inhibition in millimeters indicated the relative
susceptibility of the bacteria to the compounds 3a–j
and gentamicin (std.).
2.2.4.2 Determination of minimum inhibitory/bac-
tericidal concentration (MIC and MBC). Serial dilu-
tion technique was adopted for the MIC testing
(Ajani & Nwinyi, 2010), which was determined on the
six bacterial strains namely: Staphylococcus aureus
(ATCC 25923), Klebsiella pneumoniae (ATCC 13182),
Pseudomonas aeruginosa (ATCC 15442), and
Escherichia coli (ATCC 25922) while Streptococcus
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faecalis (LIO) and Proteus vulgaris (LIO). Serial dilution
was used to achieve the different concentrations
(from 500.00mg/mL to 3.92 mg/mL) of the synthe-
sized compounds via twofold dilution which was
prepared in a sterile plate using sterile pipette and
then mixed with 18mL of molten nutrient agar and
allowed to set. Having allowed surface of the nutri-
ent agar plate was dried, streaking with overnight
broth cultures of the bacteria was performed. The
plates were then labeled accordingly and incubated
at 37 C for up to 72 h. Afterward, the incubated
plates were consequently assessed for either pres-
ence or absence of growth. The smallest concentra-
tion of the compounds which prevented the
bacterial growth was recorded and regarded as the
MIC of the compounds. This detailed technique was
similarly repeated replacing the synthesized com-
pound with gentamicin (clinical standard).
MBC Determination: To obtain minimum bacteri-
cidal concentration (MBC), 0.1mL volume was taken
from each tube and spread on agar plates. The num-
ber of c.f.u was counted after 18–24 h of incubation
at 35 C.
3. Results and discussion
3.1 Chemistry
3.1.1. Synthetic chemistry
Molecular characterization and structural activity
relationship (SAR) studies have shown coumarin
derivatives to be highly relevant scaffolds in drug
design and medicinal research. In the review by Kale
and Patwardhan (2014), emphasis was laid on search
of coumarins linked with different heterocycles with
respect to their diverse array of biological activities.
Hence, the pyrazoline moiety was herein used as a
linker between the coumarin template and diverse
substituted benzene ring in order to evaluate the
structure activity relationship study (SAR) for possible
future drug development. Thus, in the continuation
of our research effort on the synthesis and the medi-
cinal evaluation of coumarin-based heterocycles
(Ajani et al., 2016; Ajani & Nwinyi, 2010), we have
herein reported the synthesis and antibacterial activ-
ity of novel pyrazoline-coumarin 3a-j. First and fore-
most, 3-acetyl-coumarin, 1, which is the essential
precursor herein was synthesized by the condensa-
tion reaction of salicylaldehyde and ethyl acetoace-
tate in the presence of catalytic amount of
piperidine as shown in Scheme 1. The method of
synthesis of 3-acetyl-coumarin was acquired from
the standard procedure reported by Ajani & Nwinyi
(2010) but was modified by using a solvent-free
medium, a high temperature and a very short reac-
tion time which gave a higher yield of 99.5% as
compared with yield of 92.6% obtained in the earlier
report (Ajani & Nwinyi, 2010). The condensation reac-
tion of 3-acetyl-coumarin with benzaldehyde and its
derivatives in the presence of piperidine via micro-
wave irradiation technique resulted in the formation
of a,b-unsaturated carbonyl 3-(3-(substituted-phenyl)
acryloyl)-2H-chromen-2-one 2a–j (chalcone inter-
mediates) as shown in Scheme 2. These chalcone
intermediates 2a–j were subsequently reacted with
hydrazine hydrate in solvent-free medium to give
[3þ 2]-cycloaddition products, 4,5-dihydropyrazolo-
inserted coumarin, 3a–j (Scheme 3) which are also
herein referred to as pyrazoline-linked coumarins.
Furthermore, comparative study of microwave-
assisted synthesis (MAM – Method A) of titled prod-
ucts 3a–j with that of conventional synthetic
method by heating under reflux (CSM – Method B)
was carried out and the result is as shown in Figure
1. Since % yield and kinetic are crucial parameters
for measuring the efficiency of a synthetic method,
then comparative study of microwave-assisted
method (MAM) with conventional synthetic method
(CSM) was herein evaluated with special attention on
those parameters and the result is as shown in
Figure 1. The result of the study showed that com-
pound 3a was obtained in 91% in MAM but was
obtained in 88% in CSM; compound 3b was pro-
duced in 77% using MAM whereas the yield reduced
to 71% when CSM was used. Similarly, it was
observed that MAM consistently gave the rest of the
products 3c-j in higher yields than the CSM. This
was an indication that the MAM was a more efficient
method in terms of yield assessment as descriptive
indicator of efficiency. All the pyrazoline-based cou-
marin motifs 3a–j were obtained at shorter reaction
times in MAM (1–3mins) as compared to CSM
(300–360mins). Thermodynamic justification for
faster reaction rate under microwave could be
explained by the previous work of Gude et al. (2013)
who established, by Arrhenius equation, that the
reaction rate under microwave was 1000 folds higher
than that from conventional heating approach. The
result of the physico-chemical parameters of all the
synthesized compounds is as shown in Table 1. The
molecular weight of all compounds ranged from
188.18 for compound 1 to 361.44 for compound 3j.
From the MAM, the percentage yields of the com-
pounds ranged from 63.93% being the lowest noted
in compound 3d to 99.50% being the highest
reported for precursor 1. It was noticed that slight
modification of the earlier reported method for pre-
cursor 1 synthesized resulted in the excellent and
highest yield in this present study. All the final prod-
ucts were obtained in good to excellent yields within
shortest reaction time (1–3min) under microwave
irradiation. This showed that microwave-assisted syn-
thetic route is not only environmentally friendly
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Scheme 1. Equation of reaction for the formation of 3-acetyl-coumarin, 1
Scheme 2. Microwave-assisted synthesis of chalcones 2a-j in solvent-free medium
Scheme 3. Microwave-assisted synthesis of pyrazoline-linked coumarin, 3a-j.
Figure 1. Comparative study of MAM and CSM using %yield descriptive indicator.
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approach but also efficient, atom economical and
highly productive for the synthesis of pyrazoline-
linked coumarin 3a-j.
The melting points ranged between 111 C for
compound 3a to 152–154 C for compound 3b. Out
of all the pyrazoline-based coumarin final products,
3a, which was without any substituent on phenyl,
had the lowest melting point. Hence, presence of
substituent(s) on the phenyl ring might have contrib-
uted to increase in the melting points experience in
compounds 3b–j as compared to 3a. The virtual
screening unveiled that the color varied from orange
for 3a–c and 3g–j; to yellow for 1, 3d and 3e with
compound 3f being the only brown colored com-
pound (Table 1). The disparity in color with respect
to 3f might be because it was the only final product
that possessed electron withdrawing group (EWG) as
substituent on the phenyl ring. The progress of the
reaction and the purity of the products were moni-
tored through Thin Layer Chromatography (TLC)
spotting using different solvent systems such as
dichloromethane for the intermediates chalcones
2a–j and Hexane: Ethyl acetate (9:1, v/v) as eluent
for the final products 3a–j. The elemental analytical
data results for % calculated and % found for
Carbon, Hydrogen and Nitrogen showed good
agreement with constant difference of within ±0.25
(Table 1). The values were noticed to correlate well
with molecular formula and weight parameters of
the synthesized compounds 3a–j.
3.1.2. Spectroscopic characterization
The structures of newly synthesized compounds
were elucidated by UV, IR, 1H- and 13C-NMR as well
as DEPT 135 spectroscopic data. The 1H-NMR spectra
of products 3a-j was run at 400MHz using DMSO-d6.
The most downfield signal was one proton singlet of
phenolic OH at dH of 8.88–8.80 ppm, which was fol-
lowed by the one proton singlet of heterocyclic part
(coumarin) at dH of 8.69–8.61 ppm. All the aromatic
protons resonated between dH of 7.96 ppm to
7.09 ppm which was in agreement with earlier
reported value by Chavan & Hosamani, (2018). The
NH proton resonated as doublet with dH values rang-
ing from 6.94–6.91 ppm to 6.83–6.81 ppm. This con-
firms that the thermal cyclization resulted in
pyrazoline (NH–CH) and not pyrazole. All other
shielded protons were those of the aliphatic group
and they appeared upfield between 3.40–3.36 ppm
to 2.20 ppm. The result of 13C-NMR was consistent
with the total number of carbon atoms in compound
3a–j. For instance, the 13C-NMR spectrum of com-
pound 3a showed the presence of eighteen carbon
atoms ranging from dC 195 ppm for C ¼ O to dC
45.6 ppm for CH2. Further confirmation of carbon
type was ascertained via DEPT 135 NMR spectral
data. It showed eleven positive signals from dC
147.0 ppm to dC 58.4 ppm which depicted numbers
of methine (CH) carbon atoms in 3a. The only nega-
tive signal in 3a was at dC 45.6 ppm which showed
that there was only one methylene carbon (CH2) in
the structure of pyrazoline-based coumarin 3a. The
electronic transition of uv-visible spectra in CH2Cl2
and DMSO for the intermediates chalcones 2a–j and
pyrazoline-based coumarin 3a–j respectively gave
rise to wavelength (kmax) ranging from 205 nm to
461 nm (See experimental). The first set of wave-
lengths (kmax) in each of the synthesized compounds
were found between 207 and 220 nm and they were
as a result of k!k transition of the compounds
indicating the presence of C ¼ C peculiar to ben-
zene nucleus. This indicated that all the compounds
possess benzene nucleus which was the benzenoid
of coumarin. Each of all samples showed a peak at
kmax> 200 nm and < 300 nm. The uv-visible absorp-
tion spectrum of the precursor 1 showed a peak at
kmax¼ 227 nm (log emax¼ 3.91) and other two batho-
chromic shifts at kmax¼ 290 nm and 335 nm (a shoul-
der) with log emax of 4.02 and 3.83 respectively. All
the wavelength kmax above benzenoid region (i.e.
between 290 nm to 335 nm) was as a result of k!n
transition due to contribution from C ¼ O or C ¼ N
and extended conjugation by C ¼ C groups. In add-
ition, the highest wavelength 575 nm was found in
the compound 3j, which has 4-diethylamino group.
This showed that the delocalization of the lone pair
Table 1. Physico-chemical properties of precursor 1 and synthesized compounds 3a–j.
Comp No Molecular Formula Mol. Weight %Yield Melting Point(oC) Colour
Elemental analysis %Calcd. (%Found)
C H N
1 C11H8O3 188.18 99.50 122–124 Yellow 70.10(69.97) 4.30(4.15) –
3a C18H14N2O2 290.32 91.28 111(s) Orange 74.47(74.52) 4.86(5.00) 9.65(9.78)
3b C20H19N3O2 333.38 76.82 152–154 Orange 72.05(71.89) 5.74(5.99) 12.60(12.83)
3c C19H16N2O4 336.34 91.78 143–145 Orange 67.85(68.01) 4.79(4.94) 8.33(8.20)
3d C20H18N2O3 334.37 63.93 120–121 Yellow 71.84(72.00) 5.43(5.62) 8.38(8.55)
3e C18H13N2O2Cl 324.76 96.96 150–153 Yellow 66.57(66.75) 4.03(3.97) 8.63(8.70)
3f C18H14N2O3 306.32 81.16 129–131 Brown 70.58(70.75) 4.61(4.80) 9.15(8.97)
3g C18H14N2O3 306.32 89.03 140–141 Orange 70.58(70.70) 4.61(4.79) 9.15(8.91)
3h C19H16N2O3 320.34 89.39 120–121 Orange 71.24(71.08) 5.03(4.94) 8.74(8.93)
3i C19H16N2O3 320.34 64.60 117–119 Orange 71.24(71.12) 5.03(4.90) 8.74(8.55)
3j C22H23N2O3 361.44 92.31 144–147 Orange 73.11(72.98) 6.41(6.60) 11.63(11.79)
Comp No ¼ Compound number; Mol. Weight ¼ Molecular weight; Calcd. ¼ Calculated.
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of electrons on nitrogen into the benzene nucleus
played a very contributing role to the bathochromic
shift experienced by the compound 3j. The infrared
(IR) spectra of all the compounds were run in Bruker
FT-IR. The infrared spectra of all the compounds 3a-j
showed absorption bands due to the stretching
vibration of N-H of secondary amine, C-H aliphatic,
C ¼ O of ester, C ¼ C of alkene, C ¼ N at
3443–3412 cm1, 2980–2910 cm1, 1755–1745 cm1,
1620–1601 cm1, 1593–1572 cm1 respectively. Other
bending vibrational frequencies which served as con-
firmatory bands to some specific stretching bands
were found at 1374–1362 cm1 and 1228–1220 cm1
depicting the presence of C-O and C-N functional-
ities respectively. The presence of specific broad
bands at 3350–3345 cm1 in compounds 3c, 3f and
3g was due to presence of OH of phenol in those
compounds. The prove of a successful conversion of
carbonyl of acetyl 1 to pyrazoline-based coumarins
3a–j could be established by the presence of the
C ¼ O of conjugated ketone (C ¼ C-COCH3) at
1685 cm1 in starting material 1 which disappeared
in the bands of all the products 3a–j.
3.2 Antibacterial activities
3.2.1. General in vitro sensitivity testing
Antibacterial assay was prepared according to stand-
ard method described in experimental section (Ajani
et al., 2010; Ajani & Nwinyi, 2010). Gentamicin was
used as reference drug for the antibacterial activities
according to standard method (Ajani et al., 2010;
Ajani & Nwinyi, 2010). The mode of action of genta-
micin entailed irreversible binding at ribosomal level,
thereby signaling to interrupt and truncate protein
synthesis which was the rationale for choosing gen-
tamicin as the clinical standard (Prescott et al., 2005).
The result of antibacterial screening (Sensitivity test-
ing) on bacteria with zones of inhibition in mm is as
presented in Table 2. The used precursor 1, targeted
products 3a–j and gentamicin standard were
screened in vitro against six bacterial isolates which
were two gram positive fStaphylococcus aureus
(ATCC 25923) and Streptococcus faecalis (LIO)g, and
four gram negative fKlebsiella pneumonia (ATCC
13182), Proteus vulgaris (LIO), Pseudomonas aerugi-
nosa (ATCC 15442), Escherichia coli (25922)g using
agar diffusion method. The zones of inhibition
recorded for precursor 1 against the six organisms
was from 6.00 ± 0.55mm for E. coli to
12.00 ± 0.69mm for K. pneumonia while that of titled
compounds 3a-j was from 8.00 ± 0.64mm for 3a in
E. coli to 32.00 ± 1.01mm for 3h in S. aureus.
Gentamicin standard showed activity against all the
bacteria with the zones of inhibition ranging from
4.00 ± 0.33mm for E. coli to 18.00 ± 0.88mm for P.
vulgaris. From the growth inhibition trend based on
the measured Z.O.I. pattern, pyrazoline-based cou-
marins 3a–j had larger Z.O.I. than precursor 1 which
was in turn had larger Z.O.I. than gentamicin. This
revealed that synthetic transformation of precursor 1
via functional groups interconversion to the envis-
aged coumarin motifs 3a–j was a rich-rewarding
exercise because compound 1 was never a match
for the 3a–j in their sensitivity potentials. This sug-
gested that the synthesized compounds 3a–j could
probably be a viable replacement or bioactive
enhancer for gentamicin in efficient drug design.
There were large zones of inhibition which culmi-
nated into broad spectrum of activity as shown in
the plates depicting activities of some selected com-
pounds against some selected bacterial strains
(Figure 2).
Furthermore, the result of activity index (A.I.) of
the precursor 1 and the pyrazoline-based coumarin
motifs 3a–j as compared with gentamicin standard
is as shown in Table 3. All the final products 3a–j
had higher activity indices (1.60–3.20) than gentami-
cin whereas precursor 1 had similar A.I. with the
standard against S. aureus. Measuring the activity
index against S. faecalis revealed that only 1 had a
lower activity index (0.67) than the standard while
3e was equal in A.I. with the standard and all other
targeted products 3a–d and 3f–j were higher in
their activity indices (1.33–2.00) than the standard
(1.00). It is interesting to note that all compounds
possessed better activity indices than the gentamicin
drug against K. pneumonia (1.71–3.86) and E. coli
(1.50–7.50) which were both gram-negative organ-
isms. Members of the Klebsiella genus and E. coli typ-
ically express two types of antigens on their cell
surfaces. The first, O-antigen, is a component of the
lipopolysaccharide (LPS) which plays crucial role in
antimicrobial susceptibility of E. coli and possessed
nine varieties (Ebbensgaard et al., 2018). The second
is K antigen, a capsular polysaccharide with more
than 80 varieties. Both contribute to pathogenicity
and form the basis for serogroup (DebRoy et al.,
2016). The effect of the presence of pyrazoline on
the coumarin scaffolds was also investigated by the
comparative study of the activity of the non-pyrazoli-
nized coumarin (chalcone) 2a to that of the pyrazo-
line-linked coumarin counterpart 3a as shown the
Figure 3. The zones of inhibition of 3a on all the
organisms was appreciably higher than that of 2a
except in Klebsiella pneumonia alone which might be
as a result of the mechanism of action of this gram-
negative organism and available K antigen with a
capsular polysaccharide nature in it (DebRoy et al.,
2016). It was also interesting to note that both
Staphylococcus aureus and Pseudomonas aeruginosa
developed resistance against action of non-
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pyrazolinized-coumarin (chalcone) 2a whereas pyra-
zoline-bearing coumarin 3a strongly inhibited the
growth of these two organisms with notable large
zones of inhibition of 16mm and 12mm respectively
(Figure 3). It was earlier reported by Zhang et al.
(2014) that imidazoles-linked coumarin proved to be
more promising compounds than fadrozole standard
drug as CYP450 inhibitors. The result herein obtained
with pyrazoline-linked coumarin agreed with the
findings of Zhang et al. (2014), because the pyrazo-
line-linked coumarin 3a exhibited a higher
antibacterial activity than the non-pyrazolinized cou-
marin (chalcone 2a). Hence, the use of pyrazoline as
a linker between the coumarin heterocycle and sub-
stituted phenyl groups was a worthwhile adventure
for bioactivity enhancement of these biomolecules.
3.2.2. MIC and MBC activities testing
In addition, minimum inhibitory concentration (MIC)
test of pyrazoline-based coumarins 3a–j was carried
out on six organisms using Ajani, Iyaye, et al. (2018)
method as shown in Table 4. The result excluded
Table 2. Antibacterial screening (sensitivity testing) on bacteria with zones of inhibition (mm).
Bacteria !
S. aureus S. faecalis K. pneumonia P. vulgaris P. aeruginosa E. coliComp. No#
1 10.00 ± 0.63 10.00 ± 0.61 12.00 ± 0.69 07.00 ± 0.60 07.00 ± 0.58 06.00 ± 0.55
3a 16.00 ± 0.83 22.00 ± 0.93 14 .00 ± 0.74 19.00 ± 0.88 12.00 ± 0.73 8.00 ± 0.64
3b 16.00 ± 0.82 20.00 ± 0.88 12.00 ± 0.71 10.00 ± 0.63 8.00 ± 0.60 12.00 ± 0.71
3c 16.00 ± 0.84 20.00 ± 0.89 16.00 ± 0.83 19.00 ± 0.89 14.00 ± 0.73 18.00 ± 0.87
3d 24.00 ± 0.92 28.00 ± 0.98 22.00 ± 0.91 22.00 ± 0.92 17.00 ± 0.87 22.00 ± 0.89
3e 16.00 ± 0.84 15.00 ± 0.83 14.00 ± 0.79 20.00 ± 0.89 12.00 ± 0.72 12.00 ± 0.72
3f 32.00 ± 1.00 26.00 ± 0.97 22.00 ± 0.90 26.00 ± 0.96 22.00 ± 0.92 24.00 ± 0.93
3g 28.00 ± 0.98 30.00 ± 0.99 27.00 ± 0.97 28.00 ± 0.98 29.00 ± 0.98 28.00 ± 0.98
3h 32.00 ± 1.01 20.00 ± 0.88 26.00 ± 0.98 28.00 ± 0.99 18.00 ± 0.88 30.00 ± 0.99
3i 22.00 ± 0.92 28.00 ± 0.99 20.00 ± 0.88 22.00 ± 0.92 22.00 ± 0.91 20.00 ± 0.89
3j 16.00 ± 0.85 22.00 ± 0.92 20.00 ± 0.89 20.00 ± 0.88 16.00 ± 0.85 08.00 ± 0.62
Gtm 10.00 ± 0.64 15.00 ± 0.83 07.00 ± 0.59 18.00 ± 0.88 12.00 ± 0.73 04.00 ± 0.33
Mean ± SD of triplicate measurements, S. aureus ¼ Staphylococcus aureus (ATCC 25923: Gþ), S. faecalis ¼ Streptococcus faecalis (LIO: Gþ), K.
pneumonia ¼ Klebsiella pneumonia (ATCC 13182: G-), P. vulgaris ¼ Proteus vulgaris (LIO: G-), P. aeruginosa ¼ Pseudomonas aeruginosa (ATCC
15442: G-), E. coli ¼ Escherichia coli (ATCC 25922: G-), Gþ ¼ Gram-positive, G ¼ Gram-negative, Gtm ¼ Gentamicin; ATCC ¼ American Type
Culture Collection, LIO ¼ Locally Isolated Organism.
Figure 2. The plates showing the zones of inhibition of susceptibility of: (a) S. aureus against 5a, 5 b and 5i with new codes
of 3a, 3 b, and 3c respectively (b) S. faecalis against 2d, 2e and 2f with new codes of 3d, 3 g, and 3j respectively (c) P. aerugi-
nosa against 2d, 2e and 2f with new codes of 3d, 3 g, and 3j respectively (d) E.coli against 2m, 4d and 4e with new codes
of 3f, 3e, and 3 h respectively.
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that of precursor 1 because of its low zones of inhib-
ition recorded in general sensitivity testing (Table 2)
and activity index results (Table 3). The MIC values
of growth inhibitory potential of 3a–j against gram-
positive organisms S. aureus and S. faecalis varied
from 3.91 ± 0.22mg/mL to 125.00 ± 3.02mg/mL; for
gram-negative organisms K. pneumonia and P. vulga-
ris, it ranged from 15.63 ± 0.94mg/mL to
125.00 ± 3.01 mg/mL; and for the last two gram-nega-
tive bacterial isolates P. aeruginosa and E. coli, the
MIC ranges were recorded to be 7.82 ± 0.43 mg/mL to
250.00 ± 3.92 mg/mL. The efficiency of 3a–j was
lowest against growth inhibition of P. aeruginosa
with very high MIC values of 125 mg/mL to 250 mg/
mL except for 3g (MIC¼ 7.82mg/mL) and 3j
(MIC¼ 31.25 mg/mL). This may be explained by the
hardy cell wall of this organism which contains por-
ins and efflux pumps called ABC transporters, known
to be notoriously responsible for pumping out of
some antibiotics before they are able to act. It may
also be due to the protective biofilms formed by
these organisms (Prescott et al., 2005). Upon com-
paring the efficacious trend of series of compounds
3a–j across board the bacterial isolates screened, 3j
Table 3. The activity index of the synthesized compounds against the targeted organisms.
Bacteria !
S. aureus S. faecalis K. pneumonia P. vulgaris P. aeruginosa E. coliComp. No#
1 1.00 ± 0.03 0.67 ± 0.02 1.71 ± 0.05 0.39 ± 0.02 0.58 ± 0.02 1.50 ± 0.06
3a 1.60 ± 0.05 1.47 ± 0.05 2.00 ± 0.05 1.06 ± 0.05 1.00 ± 0.05 2.00 ± 0.05
3b 1.60 ± 0.06 1.33 ± 0.05 1.71 ± 0.05 0.56 ± 0.02 0.67 ± 0.02 3.00 ± 0.10
3c 1.60 ± 0.05 1.33 ± 0.03 2.29 ± 0.07 1.06 ± 0.03 1.17 ± 0.04 4.50 ± 0.10
3d 2.40 ± 0.09 1.87 ± 0.07 3.14 ± 0.10 1.22 ± 0.04 1.42 ± 0.06 5.50 ± 0.12
3e 1.60 ± 0.05 1.00 ± 0.03 2.00 ± 0.06 1.11 ± 0.04 1.00 ± 0.04 3.00 ± 0.09
3f 3.20 ± 0.09 1.73 ± 0.05 3.14 ± 0.09 1.44 ± 0.03 1.83 ± 0.06 6.00 ± 0.14
3g 2.80 ± 0.08 2.00 ± 0.06 3.86 ± 0.10 1.56 ± 0.04 2.42 ± 0.07 7.00 ± 0.14
3h 3.20 ± 0.10 1.33 ± 0.04 3.71 ± 0.10 1.56 ± 0.05 1.50 ± 0.05 7.50 ± 0.15
3i 2.20 ± 0.07 1.87 ± 0.06 2.86 ± 0.09 1.22 ± 0.04 1.83 ± 0.06 5.00 ± 0.13
3j 1.60 ± 0.05 1.47 ± 0.04 2.86 ± 0.08 1.11 ± 0.05 1.33 ± 0.05 2.00 ± 0.07
Gtm 1.00 ± 0.04 1.00 ± 0.04 1.00 ± 0.04 1.00 ± 0.04 1.00 ± 0.04 1.00 ± 0.04
Comp. No ¼ compound number; Mean ± SD of triplicate measurements, S. aureus ¼ Staphylococcus aureus (ATCC 25923: Gþ), S.
faecalis ¼ Streptococcus faecalis (LIO: Gþ), K. pneumonia ¼ Klebsiella pneumonia (ATCC 13182: G), P. vulgaris ¼ Proteus vulgaris
(LIO: G), P. aeruginosa ¼ Pseudomonas aeruginosa (ATCC 15442: G), E. coli ¼ Escherichia coli (ATCC 25922: G-), Gþ ¼ Gram-posi-
tive, G ¼ Gram-negative, Gtm ¼ Gentamicin; ATCC ¼ American Type Culture Collection, LIO ¼ Locally Isolated Organism.
Figure 3. Comparative study of activity of chalcone 2a and pyrazoline-coumarin counterpart 3a.
Table 4. Results of minimum inhibitory concentration (MIC) of 3a-j on bacteria (mg/mL).
Bacteria !
S. aureus S. faecalis K. pneumonia P. vulgaris P. aeruginosa E. coliComp. No#
3a 31.25 ± 1.08 62.50 ± 2.00 31.25 ± 0.85 31.25 ± 0.85 125.00 ± 3.00 62.50 ± 2.02
3b 31.25 ± 1.07 62.50 ± 2.00 125.00 ± 3.03 62.50 ± 2.02 250.00 ± 3.90 250.00 ± 3.90
3c 125.00 ± 2.98 62.50 ± 2.00 62.50 ± 2.02 62.50 ± 2.02 125.00 ± 3.01 250.00 ± 3.92
3d 15.63 ± 0.92 62.50 ± 2.00 62.50 ± 2.02 31.25 ± 0.87 250.00 ± 3.90 62.50 ± 2.00
3e 31.25 ± 0.84 125.00 ± 3.02 62.50 ± 2.00 62.50 ± 2.02 250.00 ± 3.92 31.25 ± 0.87
3f 62.50 ± 2.00 62.50 ± 2.00 125.00 ± 3.03 62.50 ± 2.02 250.00 ± 3.90 62.50 ± 2.00
3g 62.50 ± 2.08 7.82 ± 0.43 125.00 ± 3.01 15.63 ± 0.92 7.82 ± 0.42 62.50 ± 2.00
3h 3.91 ± 0.22 62.50 ± 2.00 125.00 ± 3.01 125.00 ± 3.01 125.00 ± 3.00 125.00 ± 3.01
3i 125.00 ± 3.01 62.50 ± 2.00 125.00 ± 3.00 62.50 ± 2.00 250.00 ± 3.90 62.50 ± 2.00
3j 3.91 ± 0.22 3.91 ± 0.22 15.63 ± 0.94 15.63 ± 0.92 31.25 ± 0.87 7.82 ± 0.43
S. aureus ¼ Staphylococcus aureus (ATCC 23235: Gþ), S. faecalis ¼ Streptococcus faecalis (ATCC 29212: Gþ), K. pneumonia ¼ Klebsiella pneumonia
(ATCC 13882: G), P. vulgaris ¼ Proteus vulgaris (ATCC 29905: G), P. aeruginosa ¼ Pseudomonas aeruginosa (ATCC 10145: G), E. coli ¼ Escherichia
coli (ATCC 8739: G), Gþ ¼ Gram positive, G- ¼ Gram negative, Gtm ¼ Gentamicin.
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(MIC¼ 3.91 ± 0.22mg/mL) was noticed to be more
active than 3a–i (MIC> 3.91mg/mL) against S. aureus
and S. faecalis; 3j (MIC¼ 7.82 ± 0.43mg/mL) was more
effective than 3a–i (MIC> 7.82mg/mL) against E. coli;
3j (MIC¼ 15.63 ± 0.94mg/mL) was more active than
3a–i (MIC> 15.63 mg/mL) against K. pneumonia and
P. vulgaris; 3j (MIC¼ 31.25 ± 0.87mg/mL) was more
potent than 3a–i (MIC> 31.25 mg/mL) against P. aer-
uginosa. The pyrazoline-based coumarin 3j was the
most active with the lowest MIC against all the four
gram-negative and two gram-positive organisms
used herein. The minimum bactericidal concentration
(MBC) testing was determined on the series of pyra-
zoline-linked coumarin motifs 3a–j against tested
organisms to authenticate the lowest concentration
of the coumarin solution that causes death of the
organisms under the investigation (Figure 4). The
MBC ranged from 7.82 mg/mL to 500mg/mL. All MBC
values were observed to be two folds higher than
the MIC expect in the case of non-substituted phenyl
3a against K. pneumonia and P. vulgaris and electron
withdrawing group (Cl) substituted phenyl 3e
against E. coli where MBC values were four folds
higher than the MIC.
3.2.3. Structure activity relationship (SAR) study
In order to optimize the inhibitory potential of targeted
coumarin motifs 3a–j and to comprehend which sub-
stituent(s) on phenyl is/are essential for the bioactivity,
ten structurally related analogs were synthetically
achieved by thermal cyclization of chalcone 2a–j via
hydrazinolysis pathway to access pyrazoline-linked cou-
marin motifs 3a–j. The potency of the inhibitions against
S. aureus decreased in the following order: 3j 3h »
3d> 3a 3b  3e> 3f 3g > 3c 3i. This depicted
that p-p stacking character in 2H-chromen-2-one core
skeleton of coumarin worked synergistically with elec-
tron donating ability of electron donating groups (EDGs)
to cause activity boosting against growth potential of S.
aureus. Based on the in vitro screening of 3a–j against S.
faecalis, the order of activity was 3j> 3g » 3a-
d  3f 3h  3i> 3e. This is a strong indication that
presence of EWG (Cl) at 4-position as seen in 3e led to
experiencing poor activity against S. faecalis. The order
of tolerability and susceptibility of K. pneumonia to cou-
marin 3a-j showed that 3j> 3a> 3c–e  3b  3f–i.
The order of activity against P. aeruginosa was 3g > 3j »
3a 3c 3h > 3b  3d-f  3i while the trend of
activity variation against the last gram-negative organ-
ism, E. coli was 3j » 3e> 3a3d 3f 3g  3i> 3h
> 3b  3c. This SAR study showed that a substitution
is well tolerated in 3- and 4-positions template contain-
ing electron donating groups (EDG: NR2, OH, OEt, OMe),
whereas it is less tolerated when the substituent was
electron withdrawing (EWG: Cl). The Table 4 together
with Figure 4 highlighted these findings by synopsizing
all changes and their outcomes in activity retention or
loss. Addition of a methoxy group in 3- and 4-positions
as in 3c. 3h, 3i was well tolerated, as well as exchanging
this moiety to hydroxyl as in 3c, 3f, 3g. Apparently, only
EDG was accepted at position-4, because changing the
features at this position to chlorine (EWG in 3e) led to
weakening or reduction of potency in 3e as compared
to other analogs in this series. Analog 3j showed highest
potency against all six organisms and emerged as the
most active antibacterial agent with MIC of 3.92mg/mL,
surpassing the potency of the gentamicin which was
used clinical standard and positive control in all
measurements.
4. Conclusion
Toxicity of the reacting solvents and the discharge
of poisonous chemicals associated with conventional
synthesis of coumarin derivative was herein over-
come by using microwave irradiation in solvent-free
medium as eco-friendly and as greener approach
towards accessing the targeted pyrazoline-based
coumarin derivatives 3a–j. Pyrazoline-linked couma-
rin derivatives, 3a–j were successfully synthesized
Figure 4. Graphical representation of minimum bactericidal concentration (MBC) of 3a–j.
ARAB JOURNAL OF BASIC AND APPLIED SCIENCES 373
within very short reaction time and in good to excel-
lent yields. Finally, the synthesized compounds 3a–j
exhibited strong inhibitory efficiencies, most of
which were even higher than that of the gentamicin
which was the standard antibiotic used as the posi-
tive control. Compound 3j emerged as the most
potent antibacterial agent having MIC and MBC val-
ues of 3.92 ± 0.22 mg/mL and 7.82 ± 0.43 mg/mL
respectively. These analogs exhibit good candidature
for further study to ascertain the toxicological profile
which might open new window of opportunity to
novel drug design.
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